Nathaniel Kopp
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Chemical Synthesis and Analysis, Asymmetric Hydrogenation and Catalysis, Asymmetric Synthesis and Catalysis, Computational Drug Discovery Methods, Drug Solubulity and Delivery Systems
Most-Cited Works
- → Scale-up of Azide Chemistry: A Case Study(2012)46 cited
- → Development of a Concise Multikilogram Synthesis of LPA-1 Antagonist BMS-986020 via a Tandem Borylation–Suzuki Procedure(2017)45 cited
- → Design and Scale-up of a Co-processing Technology to Improve Powder Properties of Drug Substances(2019)16 cited
- → Development of a Scalable Synthetic Route to BMS-986251, Part 2: Synthesis of the Tricyclic Core and the API(2021)10 cited
- → Control Strategy for the Manufacture of Brivanib Alaninate, a Novel Pyrrolotriazine VEGFR/FGFR Inhibitor(2014)10 cited
- → Development of a Scalable Synthetic Route to BMS-986251. Part 1: Synthesis of the Cyclohexane Dicarboxylate Fragment(2021)8 cited
- → Scalable Asymmetric Synthesis of the All Cis Triamino Cyclohexane Core of BMS-813160(2021)5 cited
- → Alternative Approach to the Large-Scale Synthesis of the Densely Functionalized Pyrrolidone BMT-415200(2023)5 cited
- → CCDC 2083643: Experimental Crystal Structure Determination(2021)